The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of ALTER-PA-001 trial: A multicenter, open-label, randomized, phase II trial of anlotinib and benmelstobart in combination with AG versus AG as first-line treatment for metastatic pancreatic cancer.
 
Jiujie Cui
No Relationships to Disclose
 
Liwei Wang
No Relationships to Disclose
 
Jingyu Cao
No Relationships to Disclose
 
Ming Quan
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Mei Zhang
No Relationships to Disclose
 
Da Li
No Relationships to Disclose
 
Yingzhi Lu
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Jun Wu
No Relationships to Disclose
 
Guoliang Yao
No Relationships to Disclose
 
Zhiwei Li
No Relationships to Disclose